Gerard Michel
Vermögen: 4 Mio $ am 31.05.2026
Vermögen: 4 Mio $ am 31.05.2026
Gerard J.
Michel is Chief Executive Officer & Director at Delcath Systems, Inc. since 2020.
Mr. Michel is Independent Director at Beta Bionics, Inc. starting in 2025.
Former roles include Director at EP MedSystems, Inc. from 2007 to 2008; Chief Financial Officer & VP-Corporate Development at NPS Pharmaceuticals, Inc. from 2002 to 2007; Chief Financial Officer & VP-Corporate Development at Vericel Corp.
from 2014 to 2020; CFO, Treasurer & VP-Corporate Development at Biodel, Inc. from 2012 to 2014; and Principal at Booz Allen Hamilton International (U.K.) Ltd. from 1995 to 2002.
Education includes undergraduate studies at Rochester Christian University, graduate studies at the University of Rochester Medical Center, and an MBA from the University of Rochester Simon Business School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.03.2026 | 342’034 ( 0.98% ) | 4 Mio $ | 31.05.2026 | |
BETA BIONICS, INC. 0.08% | 21.05.2026 | 33’509 ( 0.08% ) | 406 129 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| DELCATH SYSTEMS, INC. | Vorstandsvorsitzender | 01.10.2020 |
| BETA BIONICS, INC. | Direktor/Vorstandsmitglied | 26.03.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| VERICEL CORPORATION | Finanzdirektor/CFO | 30.09.2020 |
Biodel, Inc.
Biodel, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Finanzdirektor/CFO | 01.05.2014 |
EP MedSystems, Inc.
EP MedSystems, Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Direktor/Vorstandsmitglied | 07.07.2008 |
| NPS PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.11.2007 |
Booz Allen Hamilton International (U.K.) Ltd.
Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management and technology consulting services | Corporate Officer/Principal | 01.07.2002 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
EP MedSystems, Inc.
EP MedSystems, Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Health Technology |
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vericel Corp.
Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Delcath Systems, Inc.
Delcath Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures drugs for treatment of cancer | Health Technology |
Biodel, Inc.
Biodel, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Rochester Medical Center
University of Rochester Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Booz Allen Hamilton International (U.K.) Ltd.
Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management and technology consulting services | Commercial Services |
University of Rochester Simon Business School
University of Rochester Simon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen